Corat Therapeutics GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2020-06-01
- Employees
- 1
- Market Cap
- -
Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- Corat Therapeutics Gmbh
- Target Recruit Count
- 45
- Registration Number
- NCT04674566
- Locations
- 🇩🇪
University Hospital Tübingen, Tübingen, Germany
© Copyright 2025. All Rights Reserved by MedPath